Chemical Compound Review:
CEFOTAXIME SODIUM sodium(6S,7S)-3- (acetyloxymethyl)-7...
Synonyms:
- The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. Odio, C.M., Faingezicht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Sáez-Llorens, X., Olsen, K.D., McCracken, G.H. N. Engl. J. Med. (1991)
- Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime. Lonks, J.R., Dickinson, B.P., Runarsdottir, V. N. Engl. J. Med. (1999)
- Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. Sort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruiz-del-Arbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., Ginès, P., Rodés, J. N. Engl. J. Med. (1999)
- Relapse of gram-negative bacillary meningitis after cefotaxime therapy. Bradsher, R.W. JAMA (1982)
- Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms. López, E.L., Bonesana, N.F., Rubeglio, E., Schugurensky, A., Sommersguter, G., Grinstein, S. J. Antimicrob. Chemother. (1980)
- Single-dose cefotaxime in the treatment of urinary tract infections in children: a randomized clinical trial. Repetto, H.A., MacLoughlin, G.J. J. Antimicrob. Chemother. (1984)
- Rapid evolution of a protein in vitro by DNA shuffling. Stemmer, W.P. Nature (1994)
- Cefotaxime failure in group A streptococcal meningitis. Bass, J.W. JAMA (1983)
- Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Navasa, M., Follo, A., Llovet, J.M., Clemente, G., Vargas, V., Rimola, A., Marco, F., Guarner, C., Forné, M., Planas, R., Bañares, R., Castells, L., Jimenez De Anta, M.T., Arroyo, V., Rodés, J. Gastroenterology (1996)
- Intravenous cefotaxime in children with bacterial meningitis. Belohradsky, B.H., Bruch, K., Geiss, D., Kafetzis, D., Marget, W., Peters, G. Lancet (1980)
- Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Smith, C.R., Ambinder, R., Lipsky, J.J., Petty, B.G., Israel, E., Levitt, R., Mellits, E.D., Rocco, L., Longstreth, J., Lietman, P.S. Ann. Intern. Med. (1984)
- Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Cockerill, F.R., Muller, S.R., Anhalt, J.P., Marsh, H.M., Farnell, M.B., Mucha, P., Gillespie, D.J., Ilstrup, D.M., Larson-Keller, J.J., Thompson, R.L. Ann. Intern. Med. (1992)
- Pneumococcal resistance to antibiotics. Klugman, K.P. Clin. Microbiol. Rev. (1990)
- Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Ariza, J., Xiol, X., Esteve, M., Fernández Bañeres, F., Liñares, J., Alonso, T., Gudiol, F. Hepatology (1991)
- Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Ledingham, I.M., Alcock, S.R., Eastaway, A.T., McDonald, J.C., McKay, I.C., Ramsay, G. Lancet (1988)
- Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling. Huletsky, A., Knox, J.R., Levesque, R.C. J. Biol. Chem. (1993)
- Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. Venkatachalam, K.V., Huang, W., LaRocco, M., Palzkill, T. J. Biol. Chem. (1994)
- Kinetics of beta-lactam interactions with penicillin-susceptible and -resistant penicillin-binding protein 2x proteins from Streptococcus pneumoniae. Involvement of acylation and deacylation in beta-lactam resistance. Lu, W.P., Kincaid, E., Sun, Y., Bauer, M.D. J. Biol. Chem. (2001)
- Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Brun-Buisson, C., Legrand, P., Philippon, A., Montravers, F., Ansquer, M., Duval, J. Lancet (1987)
- Penetration of cefotaxime into pancreatic juice. Benveniste, G.L., Morris, R.G. Lancet (1985)
- Intracellular replication is essential for the virulence of Salmonella typhimurium. Leung, K.Y., Finlay, B.B. Proc. Natl. Acad. Sci. U.S.A. (1991)
- Emerging role of cephalosporins in bacterial meningitis. Nelson, J.D. Am. J. Med. (1985)
- In-vitro activity of new cephalosporin (HR 756) and cefazolin. Stratford, B.C. Lancet (1978)
- In-vitro activity of new cephalosporin (HR 756) and cefazolin. Vanhoff, R., Butzler, J.P., Yourassowsky, E. Lancet (1978)
- Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for beta-lactam antibiotics. Mouz, N., Di Guilmi, A.M., Gordon, E., Hakenbeck, R., Dideberg, O., Vernet, T. J. Biol. Chem. (1999)
- Nucleotide sequences of the pbpX genes encoding the penicillin-binding proteins 2x from Streptococcus pneumoniae R6 and a cefotaxime-resistant mutant, C506. Laible, G., Hakenbeck, R., Sicard, M.A., Joris, B., Ghuysen, J.M. Mol. Microbiol. (1989)
- Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant. Saves, I., Burlet-Schiltz, O., Maveyraud, L., Samama, J.P., Promé, J.C., Masson, J.M. Biochemistry (1995)
- The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae. Moore, L.J., Pridmore, A.C., Dower, S.K., Read, R.C. J. Antimicrob. Chemother. (2004)
- Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes. Matera, G., Berlinghieri, M.C., Foti, F., Barreca, G.S., Focà, A. J. Antimicrob. Chemother. (1996)
- Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model. Ziegeler, S., Raddatz, A., Hoff, G., Buchinger, H., Bauer, I., Stockhausen, A., Sasse, H., Sandmann, I., Hörsch, S., Rensing, H. Acta anaesthesiologica Scandinavica. (2006)
- Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Rimola, A., Salmerón, J.M., Clemente, G., Rodrigo, L., Obrador, A., Miranda, M.L., Guarner, C., Planas, R., Solá, R., Vargas, V. Hepatology (1995)
- Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Moore, R.D., Smith, C.R., Lietman, P.S. Am. J. Med. (1986)
- Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery. Cox, C.E. Am. J. Med. (1989)